Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.
Kuttler
B
B
Institute of Pathophysiology, University of Greifswald, Karlsburg, Germany.
Mathieu
C
C
Bulfone-Paus
S
S
Bouillon
R
R
Diamantstein
T
T
Hahn
H J
HJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003921:Diabetes Mellitus, Experimental / Q000601:surgery*; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000601:surgery*; D006085:Graft Survival; D016381:Islets of Langerhans Transplantation / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D016688:Mice, Inbred NOD; D051381:Rats; D011913:Rats, Inbred BB; D011917:Rats, Inbred Lew; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D015996:Survival Rate; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D000911:Antibodies, Monoclonal; D015375:Receptors, Interleukin-2